Synthesis of Novel 3‐Acetyl‐2‐Aryl‐5‐(3‐Aryl‐1‐Phenyl‐Pyrazol‐4‐yl)‐2,3‐Dihydro‐1,3,4‐Oxadiazoles

A series of novel pyrazolyl‐substituted 1,3,4‐oxadiazole derivatives ( 4a‐4o ) were prepared by cyclization of the intermediate N′‐((3‐aryl‐l‐phenyl‐pyrazol‐4‐yl)methylene)arylhydrazide with acetic anhydride. The structures of the new compounds were confirmed by IR, ¹H NMR, MS and elemental analysis. Furthermore, preliminary bioassay of some of the title compounds indicated that they exhibited moderate inhibition against HIV‐1 PR.     

Methyl 4‐(2‐chloro‐5‐nitro­phenyl)‐2,7,7‐tri­methyl‐5‐oxo‐1,4,5,6,7,8‐hexa­hydro­quinoline‐3‐carboxyl­ate

The title compound, C₂₀H₂₁ClN₂O₅, has potential calcium modulatory properties. The 1,4‐di­hydro­pyridine ring has the usual shallow boat conformation. The 2‐chloro‐5‐nitro­phenyl ring is oriented such that the chloro substituent is in a synperiplanar orientation with respect to the 1,4‐di­hydro­pyridine ring plane, while the nitro substituent sits over the 1,4‐di­hydro­pyridine ring. The cyclo­hexenone ring has a conformation that is approximately half‐way between that of an envelope and that of a half‐chair. The mol­ecules are linked into chains by intermolecular N—H⋯O hydrogen bonds.     

Visible‐Light‐Induced Nickel‐Catalyzed Negishi Cross‐Couplings by Exogenous‐Photosensitizer‐Free Photocatalysis

The merging of photoredox and transition‐metal catalysis has become one of the most attractive approaches for carbon–carbon bond formation. Such reactions require the use of two organo‐transition‐metal species, one of which acts as a photosensitizer and the other one as a cross‐coupling catalyst. We report herein an exogenous‐photosensitizer‐free photocatalytic process for the formation of carbon–carbon bonds by direct acceleration of the well‐known nickel‐catalyzed Negishi cross‐coupling that is based on the use of two naturally abundant metals. This finding will open new avenues in cross‐coupling chemistry that involve the direct visible‐light absorption of organometallic catalytic complexes.     

tert‐Butyl (6S)‐4‐hydroxy‐6‐isobutyl‐2‐oxo‐1,2,5,6‐tetra­hydropyridine‐1‐carboxyl­ate and tert‐butyl (4R,6S)‐4‐hydroxy‐6‐iso­butyl‐2‐oxopiperidine‐1‐carboxyl­ate

X‐ray studies reveal that tert‐butyl (6S)‐6‐iso­butyl‐2,4‐dioxo­piperidine‐1‐carboxyl­ate occurs in the 4‐enol form, viz. tert‐butyl (6S)‐4‐hydroxy‐6‐iso­butyl‐2‐oxo‐1,2,5,6‐tetra­hydropyri­dine‐1‐carboxyl­ate, C₁₄H₂₃NO₄, when crystals are grown from a mixture of di­chloro­methane and pentane, and has an axial orientation of the iso­butyl side chain at the 6‐position of the piperidine ring. Reduction of the keto functionality leads predominantly to the corresponding β‐hydroxy­lated δ‐lactam, tert‐butyl (4R,6S)‐4‐hydroxy‐6‐iso­butyl‐2‐oxo­piperidine‐1‐car­boxyl­ate, C₁₄H₂₅NO₄, with a cis configuration of the 4‐hydroxy and 6‐iso­butyl groups. The two compounds show similar molecular packing driven by strong O—H⋯O=C hydrogen bonds, leading to infinite chains in the crystal structure.     

rac‐5‐Diphenylacetyl‐2,2,4‐trimethyl‐2,3,4,5‐tetrahydro‐1,5‐benzothiazepine and rac‐5‐formyl‐2,2,4‐trimethyl‐2,3,4,5‐tetrahydro‐1,5‐benzothiazepine

rac‐5‐Diphenylacetyl‐2,2,4‐trimethyl‐2,3,4,5‐tetrahydro‐1,5‐benzothiazepine, C₂₆H₂₇NOS, (I), and rac‐5‐formyl‐2,2,4‐trimethyl‐2,3,4,5‐tetrahydro‐1,5‐benzothiazepine, C₁₃H₁₇NOS, (II), are both characterized by a planar configuration around the heterocyclic N atom. In contrast with the chair conformation of the parent benzothiazepine, which has no substituents at the heterocyclic N atom, the seven‐membered ring adopts a boat conformation in (I) and a conformation intermediate between boat and twist‐boat in (II). The molecules lack a symmetry plane, indicating distortions from the perfect boat or twist‐boat conformations. The supramolecular architectures are significantly different, depending in (I) on C—H...O interactions and intermolecular S...S contacts, and in (II) on a single aromatic π–π stacking interaction.     

Synthesis and Self‐Assembled Helical Supramolecular Polymer of Ethyl 7,8‐dihydro‐3‐hydroxy‐9‐methyl‐7‐(4′‐nitrophenyl)‐6H‐dibenzo[c]‐ pyran‐6‐one‐8‐carboxylate

A structurally novel compound was isolated as the main product of tandem Pechmann–dehydration between diethyl 4‐hydroxy‐4‐methyl‐2‐(4′‐nitrophenyl)‐6‐oxocyclohexane‐1,3‐dicarboxylate ( 1 ) and resorcinol in the presence of trifluoroacetic acid. The structure of the product was determined as a racemate of (7R,8R)‐ and (7S,8S)‐ethyl 7,8‐dihydro‐3‐hydroxy‐9‐methyl‐7‐(4′‐nitrophenyl)‐6H‐dibenzo[c]‐pyran‐6‐one‐8‐carboxylate ( 3a ) enantiomers by single crystal X‐ray diffraction analysis. The X‐ray crystal structure revealed that 3a possesses an extended and more stable conjugated aromatic system as a consequence of the stereoselectivity of intramolecular dehydration behavior of Pechmann condensation product 2 . In the crystal superstructure, the (7R,8R)‐ and (7S,8S)‐isomers of 3a respectively self‐assembled into left‐ and right‐handed supramolecular helical chains with a channel size of 3.70 Å × 10.20 Å in virtue of intermolecular hydrogen bonding together with dramatic twisting between carboxylate group at C8 and tricyclic ring framework of 3a , which are then arranged alternatively along the b‐axis direction with a pitch length of 7.894 Å.     

Two pseudo‐enantiomeric forms of N‐benzyl‐4‐hydroxy‐1‐methyl‐2,2‐dioxo‐1H‐2λ6,1‐benzothiazine‐3‐carboxamide and their analgesic properties

The fact that molecular crystals exist as different polymorphic modifications and the identification of as many polymorphs as possible are important considerations for the pharmaceutic industry. The molecule of N‐benzyl‐4‐hydroxy‐1‐methyl‐2,2‐dioxo‐1H‐2λ⁶,1‐benzothiazine‐3‐carboxamide, C₁₇H₁₆N₂O₄S, does not contain a stereogenic atom, but intramolecular hydrogen‐bonding interactions engender enantiomeric chiral conformations as a labile racemic mixture. The title compound crystallized in a solvent‐dependent single chiral conformation within one of two conformationally polymorphic P2₁2₁2₁ orthorhombic chiral crystals (denoted forms A and B). Each of these pseudo‐enantiomorphic crystals contains one of two pseudo‐enantiomeric diastereomers. Form A was obtained from methylene chloride and form B can be crystallized from N,N‐dimethylformamide, ethanol, ethyl acetate or xylene. Pharmacological studies with solid–particulate suspensions have shown that crystalline form A exhibits an almost fourfold higher antinociceptive activity compared to form B.     

Syntheses of 2‐Keto‐3‐deoxy‐D‐xylonate and 2‐Keto‐3‐deoxy‐L‐arabinonate as Stereochemical Probes for Demonstrating the Metabolic Promiscuity of Sulfolobus solfataricus Towards D‐Xylose and L‐Arabinose

Practical syntheses of 2‐keto‐3‐deoxy‐D ‐xylonate (D ‐KDX) and 2‐keto‐3‐deoxy‐L ‐arabinonate (L ‐KDA) that rely on reaction of the anion of ethyl 2‐[(tert‐butyldimethylsilyl)oxy]‐2‐(dimethoxy phosphoryl) acetate with enantiopure glyceraldehyde acetonide, followed by global deprotection of the resultant O‐silyl‐enol esters, have been developed. This has enabled us to confirm that a 2‐keto‐3‐deoxy‐D ‐gluconate aldolase from the archaeon Sulfolobus solfataricus demonstrates good activity for catalysis of the retro‐aldol cleavage of both these enantiomers to afford pyruvate and glycolaldehyde. The stereochemical promiscuity of this aldolase towards these enantiomeric aldol substrates confirms that this organism employs a metabolically promiscuous pathway to catabolise the C5‐sugars D ‐xylose and L ‐arabinose.     

Ionic‐liquid‐based ultrasound/microwave‐assisted extraction of 2,4‐dihydroxy‐7‐methoxy‐1,4‐benzoxazin‐3‐one and 6‐methoxy‐benzoxazolin‐2‐one from maize (Zea mays L.) seedlings

We evaluated an ionic‐liquid‐based ultrasound/microwave‐assisted extraction method for the extraction of 2,4‐dihydroxy‐7‐methoxy‐1,4‐benzoxazin‐3‐one and 6‐methoxy‐benzoxazolin‐2‐one from etiolated maize seedlings. We performed single‐factor and central composite rotatable design experiments to optimize the most important parameters influencing this technique. The best results were obtained using 1.00 M 1‐octyl‐3‐methylimidazolium bromide as the extraction solvent, a 50°C extraction temperature, a 20:1 liquid/solid ratio (mL/g), a 21 min treatment time, 590 W microwave power, and 50 W fixed ultrasonic power. We performed a comparison between ionic‐liquid‐based ultrasound/microwave‐assisted extraction and conventional homogenized extraction. Extraction yields of 2,4‐dihydroxy‐7‐methoxy‐1,4‐benzoxazin‐3‐one and 6‐methoxy‐benzoxazolin‐2‐one by the ionic‐liquid‐based ultrasound/microwave‐assisted extraction method were 1.392 ± 0.051 and 0.205 ± 0.008 mg/g, respectively, which were correspondingly 1.46‐ and 1.32‐fold higher than those obtained by conventional homogenized extraction. All the results show that the ionic‐liquid‐based ultrasound/microwave‐assisted extraction method is therefore an efficient and credible method for the extraction of 2,4‐dihydroxy‐7‐methoxy‐1,4‐benzoxazin‐3‐one and 6‐methoxy‐benzoxazolin‐2‐one from maize seedlings.     

New routes to 1‐functionally substituted arylbenzotriazoles: 3‐Benzotriazol‐1‐yl‐pyridazine‐4‐ones, 5‐benzotriazol‐1‐yl‐pyridazine‐6‐ones and 5‐benzotriazol‐1‐yl‐pyridazine‐6‐imines

Condensation of 1‐arylhydrazono‐1‐benzotriazol‐1‐yl 2‐propanones ( 5a‐c ) with DMF DMA afforded 1‐aryl‐3‐benzotriazol‐1‐yl‐1,4‐dihydropyridazine‐4‐ones ( 8a‐c ). While condensation of 1‐functionally substituted methylbenzotriazoles 3b,c with 2‐arylhydrazono‐3‐oxoarylpropanal 13a,b give 3‐aroyl‐5‐(benzo‐triazolyl‐1‐yl)‐1,6‐dihydro‐1‐phenylpyridazine‐6‐ones and 6‐imines 14a‐d.     

具有U构型的二{1-甲硫基-1-[1-苯基-1-(1-苯基-3-甲基-5-氧代-4,5二氢吡唑-4-烯)-甲氨基]亚氨甲基}二硫醚的晶体结构

The reaction of 1-phenyl-3-methyl-4-benzoyl-2,5-dihydro-1H-pyrazol-5-one (PMBP) and methyldithiocarbazate (mdtc) in methanol results in formation of a yellow crystalline solid, adduct of 1-phenyl-3-methyl-4benzoyl-2,5-dihydro-lH-pyrazol-5-one and methyldithiocarbazate. When the yellow solids were dissolved in a mixture of methanol and ether (1:4), a red crystal, which is an oxidation product of the former, was obtained by allowing solvent to evaporate for a few days at room temperature. The X-ray analysis of the red crystal indicates that it is a novel disulfide with a special structure like a “U” conformation in the solid state.     

Synthesis,Characterization and Antimicrobial Activity of 1,2‐dihydroquinoxaline‐3‐yl‐3‐Substitutedphenyl‐1H‐pyrazole‐4‐Carbaldehyde

A series of 1,2‐dihydroquinoxaline‐3‐yl‐3‐substitutedphenyl‐1H‐pyrazole‐4‐carbaldehyde were synthesized and evaluated for their antimicrobial activity against two Gram‐positive and two Gram‐negative organisms and two fungal organisms. The study has shown that pyrazole‐4‐carbaldehyde‐incorporated quinoxaline was essential for activity. Among the compounds, 5a , 5c , 5d had shown significant activity against all selected strains when compared with control. These compounds may prove useful as antimicrobial agents.     

Synthesis,Characterization, and Anti‐inflammatory Activity of Novel Isoxazolyl‐4‐(2‐oxo‐2,3‐dihydro‐1H‐3‐indolyl)pyrrole‐3‐carboxylates

A series of novel isoxazolyl‐4‐(2‐oxo‐2,3‐dihydro‐1H‐3‐indolyl)pyrrole‐3‐carboxylates ( 17a – i) were synthesized by a three‐component reaction of 4‐amino‐3‐methyl‐5‐styrylisoxazole 14 , β‐keto ester 15 , and 3‐phenacylideneoxindole 16 , in the presence of CAN catalyst in ethanol. The structures of the synthesized compounds have been established on the basis of spectral and analytical data. The title compounds 17a – i were evaluated for their anti‐inflammatory activity. Compounds 17b and 17c exhibited potent anti‐inflammatory activity as that of standard drug.     

Synthesis of N‐aryl‐2‐amino‐4‐oxo‐3,4‐dihydrothieno[2,3‐d]pyrimidine‐6‐carboxamides

Synthetic routes for the preparation of methyl 2‐amino‐4‐methoxythieno[2,3‐d]pyrimidine‐6‐carboxylate (4) ‐ useful intermediate for lipophilic and classical antifolates from 2‐amino‐4,6‐dichloropyrimidine‐5‐car‐baldehyde (1) have been studied. It has been shown that more efficient synthesis of compound 4 includes the preparation of 4‐methoxy derivative 7 and subsequent tandem substitution/annulation reaction with methyl mercaptoethanoate in dimethylformamide in the presence of potassium carbonate and molecular sieves 4 Å. Compound 4 was used for the synthesis of N‐aryl 2‐amino‐4‐oxo‐3,4‐dihydrothieno[2,3‐d]‐pyrimidine‐6‐carboxamides 10a‐c, including an analog of folic acid with amide bridge ‐ N‐(4‐{[(2‐amino‐4‐oxo‐3,4‐dihydrothieno[2,3‐d]pyrirnidin‐6‐yl)carbonyl]amino}‐benzoyl)‐L‐glutamic acid (10c) .     

Synthesis and Antibacterial Activities of 2‐(1‐Aryl‐5‐Methyl‐1,2,3‐triazol‐4‐yl)‐1,3,4‐Oxadiazole Derivatives

Eighteen novel 2‐(1‐aryl‐5‐methyl‐1,2,3‐triazol‐4‐yl)‐1,3,4‐oxadiazole derivatives and two acylhydrazone intermediate compounds were synthesized by various pathways starting from 1‐aryl‐5‐methyl‐1,2,3‐triazol‐4‐formhydrazide ( 1 ). All products were identified by spectroscopic analysis, and 2‐(1‐aryl‐5‐methyl‐1,2,3‐triazol‐4‐yl)‐5‐benzalthio‐1,3,4‐oxadiazole was further validated by X‐ray crystallography. Results from primary antibacterial activity tests indicated that most of the compounds were effective against E. coli, P. aeruginosa, B. subtilis and S. aureus.     

Synthesis and antimicrobialactivity of 2‐alkylcarbamato‐2,3‐dihydro‐5‐propylthio‐1H‐1,3,2‐benzodiazaphosphole 2‐oxides

Novel 2‐alkylcarbamato/thiocarbama‐to‐2,3‐dihydro‐5‐propylthio‐1H‐1,3,2‐benzodiazaphos‐phole 2‐oxides ( 4a–J ) were synthesized by cyclization of 4‐propylthio‐1,2‐phenylenediamine ( 3 ) with the corresponding dichlorophosphoryl carbamates/thiocarbamates ( 2a–J ) that were obtained by the addition of alcohols/thiols to isocyanatophosphoryl dichloride ( 1 ). The structures of the title compounds were confirmed by the ¹H, ¹³C, ³¹P NMR, and mass spectral studies. Some of these products were found to possess significant antimicrobial activity. © 2000 John Wiley & Sons, Inc. Heteroatom Chem 11:336–340, 2000     

Efficient Diketopyrrolopyrrole‐Based Small‐Molecule Bulk‐Heterojunction Solar Cells with Different Electron‐Donating End‐Groups

A series of small molecules that contained identical π‐spacers (ethyne), a central diketopyrrolopyrrole (DPP) unit, and different aromatic electron‐donating end‐groups were synthesized and used in organic solar cells (OSCs) to study the effect of electron‐donating groups on the device performance. The three compounds, DPP‐A‐Ph , DPP‐A‐Na , and DPP‐A‐An , possessed intense absorption bands that covered a wide range, from 350 to 750 nm, and relatively low HOMO energy levels, from ?5.50 to ?5.55 eV. DPP‐A‐An , which contained anthracene end‐groups, demonstrated a stronger absorbance and a higher hole mobility than DPP‐A‐Ph , which contained phenyl groups, and DPP‐A‐Na , which contained naphthalene units. The power‐conversion efficiencies (PCEs) of OSCs based on organic:PC₇₁BM blends (1:1, w/w) with a processed DIO additive were 3.93 % for DPP‐A‐An , 3.02 % for DPP‐Na , and 2.26 % for DPP‐A‐Ph . These findings suggest that a DPP core that is functionalized with electron‐donating capping groups constitutes a promising new class of solution‐processable small molecules for OSC applications.     

A simple synthesis of 5‐ethoxycarbonyl‐6‐phenyl‐1,3‐dioxin‐4‐ones and ethyl 3‐benzoyl‐4‐oxo‐2,6‐diphenylpyran‐5‐carboxylate

4‐Ethoxycarbonyl‐5‐phenyl‐2,3‐dihydrofuran‐2,3‐dione 1 reacts with aldehydes via the acylketene intermediate 2 giving the 1,3‐dioxin‐4‐ones 3a‐e and the 1,4‐bis(5‐ethoxycarbonyl‐4‐oxo‐6‐phenyl‐4H‐1,3‐dioxin‐2‐yl)benzene 4 , and a one step reaction between dibenzoylmethane and oxalylchloride gave 3,5‐dibenzoyl‐2,6‐diphenyl‐4‐pyrone 7 . The reaction of 1 with dibenzoylmethane, a dicarbonyl compound, provided ethyl 3‐benzoyl‐4‐oxo‐2,6‐diphenylpyran‐5‐carboxylate derivative 9 . Compound 9 was converted into the corresponding ethyl 3‐benzoyl‐4‐hydroxy‐2,6‐diphenylpyridine‐5‐carboxylate derivative 10 via its reaction with ammonium hydroxyde solution in 1 ‐butanol.     

Synthesis of some new 1‐acyl‐5‐aryl‐3‐(5‐methyl‐1‐p‐tolyl‐1H‐1,2,3‐triazol‐4‐yl)‐4,5‐dihydro‐1H‐pyrazole

Some new compounds (E)‐3‐aryl‐1‐(5‐methyl‐1‐p‐tolyl‐1H‐1,2,3‐triazol‐4‐yl)‐prop‐2‐en‐1‐ones 5a–e were prepared by 1‐(5‐methyl‐1‐p‐tolyl‐1H‐1,2,3‐triazol‐4‐yl)‐ethanone and various aromatic aldehydes. Then one pot reaction was happened by compounds 5a–e with hydrazine hydrate in acetic acid or propionic acid, respectively, to give the title compounds 1acyl‐5‐aryl‐3‐(5‐methyl‐1‐p‐tolyl‐1H‐1,2,3‐triazol‐4‐yl)‐4,5‐dihydro‐1H‐pyrazoles 6a–i . All structures were established by MS, IR, CHN, ¹H‐NMR and ¹³C‐NMR spectral data. J. Heterocyclic Chem., (2012).     

Unusual tosyl transfer solvolysis reaction to 3‐n‐butyl‐4‐methyl‐5,5‐di‐p‐toluenesulfonyl‐ 3 ‐pyrrolin‐2‐one

The title compound ( 1 ) was isolated in 20‐30% recovery following solvolysis of a mixture of 5‐bromo‐3‐n‐butyl‐4‐methyl‐2‐p‐toluenesulfonylpyrrole ( 4b ) and 5‐bromo‐4‐n‐butyl‐3‐methyl‐2‐p‐toluenesulfonyl‐pyrrole ( 4a ) in trifluoroacetic acid and water, a reaction designed to produce 5‐p‐toluenesulfonyl‐3‐pyrrolin‐2‐ones, e.g., 5a and 5b .